JNJ-95597528

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-95597528, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]